Compared to data obtained from control mice, there was no significant difference in the percentage of NF200- or peripherin-positive neurons in SMA mice treated with AAV9-UBA1 (Fig. 7E and F). This evidence concerns the gene PRPH and proximal spinal muscular atrophy.